Episode Details

Kings College Londons puberty blocker trial for gender dysphoria kids halted due to safety concerns. The Medicines and Healthcare products Regulatory Agency insists on a minimum age of fourteen. Talks to address wellbeing concerns begin next week. The study, aiming to sign up 226 young people, was originally set to start at ten or eleven for girls and eleven or twelve for boys. The regulators letter suggests a stepwise start at fourteen, possibly dropping lower later if early results are safe. Both sides prioritize kids safety and rigorous science. NordVPN — Online privacy & security thednn.ai/nord